Synergistic interactions between cannabinoid and opioid analgesics
- PMID: 14706563
- DOI: 10.1016/j.lfs.2003.09.038
Synergistic interactions between cannabinoid and opioid analgesics
Abstract
Cannabinoids and opioids both produce analgesia through a G-protein-coupled mechanism that blocks the release of pain-propagating neurotransmitters in the brain and spinal cord. However, high doses of these drugs, which may be required to treat chronic, severe pain, are accompanied by undesirable side effects. Thus, a search for a better analgesic strategy led to the discovery that delta 9-tetrahydrocannabinol (THC), the major psychoactive constituent of marijuana, enhances the potency of opioids such as morphine in animal models. In addition, studies have determined that the analgesic effect of THC is, at least in part, mediated through delta and kappa opioid receptors, indicating an intimate connection between cannabinoid and opioid signaling pathways in the modulation of pain perception. A host of behavioral and molecular experiments have been performed to elucidate the role of opioid receptors in cannabinoid-induced analgesia, and some of these findings are presented below. The aim of such studies is to develop a novel analgesic regimen using low dose combinations of cannabinoids and opioids to effectively treat acute and chronic pain, especially pain that may be resistant to opioids alone.
Similar articles
-
Ventilatory-depressant effects of opioids alone and in combination with cannabinoids in rhesus monkeys.Eur J Pharmacol. 2018 Aug 15;833:94-99. doi: 10.1016/j.ejphar.2018.05.041. Epub 2018 May 26. Eur J Pharmacol. 2018. PMID: 29807027 Free PMC article.
-
Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.Neuropsychopharmacology. 2005 Nov;30(11):2035-45. doi: 10.1038/sj.npp.1300720. Neuropsychopharmacology. 2005. PMID: 15812567
-
Interaction of the cannabinoid and opioid systems in the modulation of nociception.Int Rev Psychiatry. 2009 Apr;21(2):143-51. doi: 10.1080/09540260902782794. Int Rev Psychiatry. 2009. PMID: 19367508 Review.
-
Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys.Psychopharmacology (Berl). 2015 Oct;232(19):3637-47. doi: 10.1007/s00213-015-4023-x. Epub 2015 Jul 23. Psychopharmacology (Berl). 2015. PMID: 26202613
-
Opioids and cannabinoids interactions: involvement in pain management.Curr Drug Targets. 2010 Apr;11(4):462-73. doi: 10.2174/138945010790980303. Curr Drug Targets. 2010. PMID: 20017728 Review.
Cited by
-
Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse.Prog Mol Biol Transl Sci. 2013;117:207-65. doi: 10.1016/B978-0-12-386931-9.00009-X. Prog Mol Biol Transl Sci. 2013. PMID: 23663971 Free PMC article. Review.
-
G-protein-coupled heteromers: regulation in disease.Methods Enzymol. 2013;521:219-38. doi: 10.1016/B978-0-12-391862-8.00012-0. Methods Enzymol. 2013. PMID: 23351742 Free PMC article.
-
The Endocannabinoid System Contributes to Electroacupuncture Analgesia.Front Neurosci. 2021 Feb 18;14:594219. doi: 10.3389/fnins.2020.594219. eCollection 2020. Front Neurosci. 2021. PMID: 33679287 Free PMC article. Review.
-
Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.Eur J Pharmacol. 2007 Oct 1;571(2-3):129-37. doi: 10.1016/j.ejphar.2007.06.001. Epub 2007 Jun 12. Eur J Pharmacol. 2007. PMID: 17603035 Free PMC article.
-
Marijuana and Prescription Pain Reliever Use among Cigarette Smokers.J Psychoactive Drugs. 2018 Sep-Oct;50(4):339-347. doi: 10.1080/02791072.2018.1506598. Epub 2018 Aug 17. J Psychoactive Drugs. 2018. PMID: 30118622 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
